In Vivo and Clinical Studies of Natural Products Targeting the Hallmarks of Cancer
Handbook of Experimental Pharmacology · 2025
DOI: 10.1007/164_2024_716 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Handbook of Experimental Pharmacology, 2025. Verfasst von Mohamed Elbadawi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Biology, Institute of Pharmaceutical and Biomedical Sciences, Johannes Gutenberg University, Mainz, Germany. Hauptthemen laut MEDLINE: Biological Products, Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 125 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Biology, Institute of Pharmaceutical and Biomedical Sciences, Johannes Gutenberg University, Mainz, Germany.
- Department of Pharmaceutical Biology, Institute of Pharmaceutical and Biomedical Sciences, Johannes Gutenberg University, Mainz, Germany. efferth@uni-mainz.de.
Zitieren
APA
Elbadawi, M., & Efferth, T. (2025). In Vivo and Clinical Studies of Natural Products Targeting the Hallmarks of Cancer. Handbook of Experimental Pharmacology. https://doi.org/10.1007/164_2024_716
Vancouver
Elbadawi M, Efferth T. In Vivo and Clinical Studies of Natural Products Targeting the Hallmarks of Cancer. Handbook of Experimental Pharmacology. 2025. doi:10.1007/164_2024_716
BibTeX
@article{Elbadawi2025,
author = {Elbadawi, Mohamed and Efferth, Thomas},
title = {In Vivo and Clinical Studies of Natural Products Targeting the Hallmarks of Cancer},
journal = {Handbook of Experimental Pharmacology},
year = {2025},
doi = {10.1007/164_2024_716}
}
EUVIMED